- Healthy infants aged 2 months (42-98 days) at time of enrolment.
- Available for the entire study period and whose parent/legal guardian can be reached
- Previous vaccination with licensed or investigational pneumococcal vaccine.
- A previous anaphylactic reaction to any vaccine or vaccine-related component.
- Contraindication to vaccination with a pneumococcal conjugate vaccine.